USD478983S1 - Inhaler - Google Patents

Inhaler Download PDF

Info

Publication number
USD478983S1
USD478983S1 US29/159,906 US15990602F USD478983S US D478983 S1 USD478983 S1 US D478983S1 US 15990602 F US15990602 F US 15990602F US D478983 S USD478983 S US D478983S
Authority
US
United States
Prior art keywords
inhaler
cap
elevational view
front
cap removed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US29/159,906
Inventor
Richard A. Whitehall
Tucker Fort
Reed R. DeWinter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Philip Morris USA Inc
Original Assignee
Chrysalis Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chrysalis Technologies Inc filed Critical Chrysalis Technologies Inc
Priority to US29/159,906 priority Critical patent/USD478983S1/en
Assigned to CHRYSALIS TECHNOLOGIES INCORPORATED reassignment CHRYSALIS TECHNOLOGIES INCORPORATED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DEWINTER, REED R., FORT, TUCKER, WHITEHALL, RICHARD A.
Application granted granted Critical
Publication of USD478983S1 publication Critical patent/USD478983S1/en
Assigned to PHILIP MORRIS USA INC. reassignment PHILIP MORRIS USA INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: CHRYSALIS TECHNOLOGIES INCORPORATED
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links

Images

Description

FIG. 1 is a front, side perspective view of an inhaler showing our new design with the cap in place.

FIG. 2 is a front, side perspective view thereof with the cap removed.

FIG. 3 is a front elevational view thereof with the cap removed.

FIG. 4 is a front elevational view thereof with the cap in place.

FIG. 5 is a side elevational view thereof with the cap removed; the other side being a mirror image thereof.

FIG. 6 is a rear elevational view thereof with the cap removed.

FIG. 7 is a top plan view thereof; and,

FIG. 8 is a bottom plan view thereof.

The broken line showing of the numerical and graphical representations shown in the LCD display in FIGS. 1-4 are for illustrative purposes only and form no part of the claimed design.

Claims (1)

  1. The ornamental design for an inhaler, as shown and described.
US29/159,906 2002-05-01 2002-05-01 Inhaler Expired - Lifetime USD478983S1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US29/159,906 USD478983S1 (en) 2002-05-01 2002-05-01 Inhaler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/159,906 USD478983S1 (en) 2002-05-01 2002-05-01 Inhaler

Publications (1)

Publication Number Publication Date
USD478983S1 true USD478983S1 (en) 2003-08-26

Family

ID=27756699

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/159,906 Expired - Lifetime USD478983S1 (en) 2002-05-01 2002-05-01 Inhaler

Country Status (1)

Country Link
US (1) USD478983S1 (en)

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060102175A1 (en) * 2004-11-18 2006-05-18 Nelson Stephen G Inhaler
US20070045288A1 (en) * 2005-09-01 2007-03-01 Nelson Stephen G Inhaler
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US8997753B2 (en) 2012-01-31 2015-04-07 Altria Client Services Inc. Electronic smoking article
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
USD771798S1 (en) * 2014-06-17 2016-11-15 Koninklijke Philips N.V. Handheld respiratory device
USD776255S1 (en) * 2014-06-17 2017-01-10 Koninklijke Philips N.V. Handheld respiratory device
USD776254S1 (en) * 2014-06-17 2017-01-10 Koninklijke Phlips N.V. Handheld respiratory device
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
USD829373S1 (en) * 2017-12-19 2018-09-25 Shenzhen Goldreams Technology Co., Ltd. Electronic cigarette
USD829981S1 (en) * 2017-05-08 2018-10-02 Smiss Technology Co., Ltd. Electronic cigarette
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
USD846798S1 (en) * 2017-04-25 2019-04-23 Shenzhen Smoore Technology Limited Electronic cigarette
USD846796S1 (en) * 2017-05-24 2019-04-23 Shenzhen Smoore Technology Limited Electronic cigarette

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US20060102175A1 (en) * 2004-11-18 2006-05-18 Nelson Stephen G Inhaler
US20070125765A1 (en) * 2005-09-01 2007-06-07 Nelson Stephen G Inhaler
US20070045288A1 (en) * 2005-09-01 2007-03-01 Nelson Stephen G Inhaler
US7186958B1 (en) 2005-09-01 2007-03-06 Zhao Wei, Llc Inhaler
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US8499757B2 (en) 2008-06-13 2013-08-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9393372B2 (en) 2008-06-13 2016-07-19 Mannkind Corporation Dry powder drug delivery system
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8912193B2 (en) 2008-06-13 2014-12-16 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8636001B2 (en) 2008-06-13 2014-01-28 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US8997753B2 (en) 2012-01-31 2015-04-07 Altria Client Services Inc. Electronic smoking article
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
USD771798S1 (en) * 2014-06-17 2016-11-15 Koninklijke Philips N.V. Handheld respiratory device
USD776254S1 (en) * 2014-06-17 2017-01-10 Koninklijke Phlips N.V. Handheld respiratory device
USD776255S1 (en) * 2014-06-17 2017-01-10 Koninklijke Philips N.V. Handheld respiratory device
USD846798S1 (en) * 2017-04-25 2019-04-23 Shenzhen Smoore Technology Limited Electronic cigarette
USD829981S1 (en) * 2017-05-08 2018-10-02 Smiss Technology Co., Ltd. Electronic cigarette
USD846796S1 (en) * 2017-05-24 2019-04-23 Shenzhen Smoore Technology Limited Electronic cigarette
USD829373S1 (en) * 2017-12-19 2018-09-25 Shenzhen Goldreams Technology Co., Ltd. Electronic cigarette

Similar Documents

Publication Publication Date Title
USD526569S1 (en) Container
USD501218S1 (en) Eyeglasses
USD467349S1 (en) Analyzer
USD445821S1 (en) Eyeglass components
USD503949S1 (en) Eyeglasses
USD481484S1 (en) Light
USD490567S1 (en) Capsule
USD474224S1 (en) Pair of eyeglasses
USD481640S1 (en) Bottle with cap
USD495957S1 (en) Bottle with oval flip top
USD483615S1 (en) Beverageware
USD485942S1 (en) Capsule
USD495961S1 (en) Bottle
USD511005S1 (en) Wound dressing
USD627059S1 (en) Nasal interface
USD489626S1 (en) Bottle
USD516211S1 (en) Inhaler
USD502179S1 (en) Image displayer
USD522372S1 (en) Bottle
USD488627S1 (en) Display frame
USD449537S1 (en) Combined bottle and cap
USD482933S1 (en) Beverageware
USD495536S1 (en) Merchandise display base
USD459487S1 (en) Landscape block
USD486743S1 (en) Portion of a bottle